3941 - 3950 of 9104 Results
Title
Year
-
OPENTitle: Updated Parkinson's disease motor subtypes classification and correlation to cerebrospinal homovanillic acid and 5-hydroxyindoleacetic acid levelsJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 8Issue #:Start Page: 100187End Page: 100187Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2023.100187Best OA location URL: https://doi.org/10.1016/j.prdoa.2023.100187Citation Count: 21
-
RESTRICTEDTitle: Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 14Issue #: 10Start Page: 1002End Page: 1009Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(15)00178-7Best OA location URL: http://doi.org/10.1016/S1474-4422(15)00178-7Citation Count: 224
-
OPENTitle: Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 16Issue #: 1Start Page: 66End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(16)30328-3Best OA location URL: http://doi.org/10.1016/S1474-4422(16)30328-3Citation Count: 435
-
OPENTitle: Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohortsJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 16Issue #: 8Start Page: 620End Page: 629Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(17)30122-9Best OA location URL: https://www.repository.cam.ac.uk/handle/1810/267006Citation Count: 189
-
OPENTitle: Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validationJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 16Issue #: 11Start Page: 908End Page: 916Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(17)30328-9Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5693218Citation Count: 159
-
OPENTitle: Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 71End Page: 80Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30319-9Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/133485Citation Count: 139
-
OPENTitle: Increased striatal dopamine in carriers of GBA mutations: compensation or epiphenomenon?Journal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 1Start Page: 27End Page: 29Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30355-2Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6924570Citation Count: 1
- Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trial2020RESTRICTEDTitle: Safety and immunogenicity of the α-synuclein active immunotherapeutic PD01A in patients with Parkinson's disease: a randomised, single-blinded, phase 1 trialJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 19Issue #: 7Start Page: 591End Page: 600Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30136-8Citation Count: 147
-
OPENTitle: Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning studyJournal Name: The Lancet Digital HealthPublisher: Elsevier BVVol: 1Issue #: 5Start Page: e222End Page: e231Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/s2589-7500(19)30105-0Best OA location URL: http://www.thelancet.com/article/S2589750019301050/pdfCitation Count: 119
- α-synuclein seed amplification in Parkinson's disease – Authors' reply2023OPENTitle: α-synuclein seed amplification in Parkinson's disease – Authors' replyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 22Issue #: 11Start Page: 985End Page: 986Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00371-xCitation Count: 7